Determining the Right Acupuncture for Good Recovery Over Neuropsychiatric Trauma
Launched by PAUL CRAWFORD · Aug 24, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific acupuncture treatment can help reduce symptoms of Post-Traumatic Stress Disorder (PTSD) in individuals who have experienced neuropsychiatric trauma. The goal is to see if this acupuncture method can improve the well-being of people diagnosed with PTSD, particularly those who have served in the military or are connected to military families.
To participate, you need to be between 18 and 65 years old and meet certain criteria for PTSD. This includes having a score of 31 or higher on a PTSD assessment tool. However, if you are pregnant, have had recent mental health hospitalizations, or are currently receiving other treatments for PTSD, you won't be eligible for this study. Participants will receive acupuncture at Nellis Air Force Base and can expect to be part of a supportive environment focused on their recovery. It's important to note that if a participant becomes pregnant during the study, they will be asked to withdraw for safety reasons.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Active Duty members and DoD beneficiaries(i.e. former military, spouse, dependent child), 18-65 years old
- • Meeting the criteria for PTSD based on PCL-5 (past month scores) score of 31 or higher
- • At least 1 positive response to at least one item on the LEC-5.
- Exclusion Criteria:
- • Pregnant, may be pregnant, or attempting to become pregnant. There areno known risks of this acupuncture in pregnant patients; however, we will exclude pregnancy due to the location of the needles (right over the uterus in 3rd trimester) and risk of exacerbating anxiety that may cause stress on the baby. Subjects will be told to let us know if they become pregnant so we can disenroll them from the study.
- • Prior treatment with Dragons acupuncture
- • History of hospitalization for mental health reasons within the last year
- • Active Suicidal thoughts (is currently considering suicide or has a plan) or suicide attempt within the last year. This will be assessed by direct questioning.
- • Is currently receiving acupuncture or other non-medication treatments specifically for PTSD (patients can elect to forgo PTSD treatments during the study period and then resume after the study period is over; ie halt therapy during the study period)
- • Legally Authorized Representatives will not be utilized in this study
- • \*\*Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study\*\*
About Paul Crawford
Paul Crawford is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, Crawford leads initiatives that support the development of novel therapies across various therapeutic areas. The organization emphasizes rigorous adherence to regulatory standards and ethical practices, ensuring that all trials are conducted with the utmost care for participant safety and data integrity. By fostering collaboration among researchers, healthcare professionals, and stakeholders, Paul Crawford aims to contribute significantly to the scientific community and improve healthcare solutions worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nellis Air Force Base, Nevada, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials